Skip to main content

Table 2 Proportion of Eligible Patients on Preventive Medications by Baseline Characteristics

From: Recent hospitalization for Non-coronary events and use of preventive medications for coronary artery disease: An observational cohort study

Characteristic Prescribed Medication, %
(n = Eligible Patients)
  Aspirin
(n = 10,296)
B-blocker
(n = 13,148)
ACE-I/ARB
(n = 10,367)
Lipid lowering
(n = 12,949)
All Meds
(n = 8,267)
All eligible patients 58.3 70.2 60.3 64.8 25.0
Age (yrs)      
   < 55 58.0 65.6 54.3 61.5 23.5
   55-65 59.3 70.3 60.4 66.8 28.3
   65-75 56.2 73.9 64.6 69.2 25.7
   ≥ 75 59.0 68.8 58.9 61.2 21.3
Female 57.6 67.3 60.5 63.3 20.2
Ethnicity      
   White 60.1 71.7 60.9 66.2 26.1
   Non-white 60.9 69.3 63.6 62.8 25.7
   Unknown 53.5 67.7 57.3 63.0 22.6
Socioeconomic status      
   Low 57.2 70.3 60.8 63.9 24.4
   Middle 62.1 70.9 60.3 65.0 26.5
   High 50.9 67.3 57.4 68.0 22.5
Current smoker 56.3 66.4 55.9 63.0 23.8
CABG 63.3 79.1 66.5 75.0 32.8
PCI 65.3 77.2 65.4 72.9 32.4
Hypertension 59.1 72.1 64.4 66.7 26.6
Hyperlipidemia 59.7 72.7 62.6 70.6 27.4
Diabetes 62.4 76.3 70.7 68.8 29.8
Heart failure 61.9 76.8 70.0 67.3 30.9
Cerebral vascular disease 59.1 71.2 63.3 66.0 24.5
Peripheral vascular disease 61.1 73.4 64.3 67.5 25.9
Chronic kidney disease 59.2 76.4 60.9 67.5 27.4
COPD 57.7 67.2 59.7 63.5 22.7
  1. Data was complete for all covariates with the exception of ethnicity. ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; CABG = coronary artery bypass grafting; PCI = percutaneous coronary intervention; COPD = chronic obstructive pulmonary disease.